Hypoxia-Inducible Factor 1 Inhibitors

Methods in Enzymology

Volumn 435, Issue , 2007, Pages 385-402

  Melillo, Giovanni ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 17 DEMETHOXY 17 (2 DIMETHYLAMINOETHYLAMINO)GELDANAMYCIN; 4 [BIS(2 CHLOROETHYL)OXIDOAMINO]PHENYLALANINE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE INHIBITOR; ECHINOMYCIN; GELDANAMYCIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1 INHIBITOR; NATURAL PRODUCT; NSC 50352; POLYAMIDE; PROTEIN INTERACTING WITH PROTEIN KINASE C; TANESPIMYCIN; THIOREDOXIN 1; TOPOTECAN; UNCLASSIFIED DRUG; DNA;

BIOASSAY; CELL FREE SYSTEM; DNA BINDING; DRUG MECHANISM; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; DNA; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MICE; TRANSCRIPTION, GENETIC;

EID: 39749142173     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)35020-9     Document Type: Review

References (34)

1. Chau N.M., Rogers P., Aherne W., Carroll V., Collins I., McDonald E., Workman P., and Ashcroft M. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res. 65 (2005) 4918-4928
2. Dames S.A., Martinez-Yamout M., De Guzman R.N., Dyson H.J., and Wright P.E. Structural basis for HIF-1α/CBP recognition in the cellular hypoxic response. Proc. Natl Acad. Sci. USA 99 (2002) 5271-5276
3. Darnell Jr. J.E. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer 2 (2002) 740-749
4. Erbel P.J., Card P.B., Karakuzu O., Bruick R.K., and Gardner K.H. Structural basis for PAS domain heterodimerization in the basic helix-loop-helix PAS transcription factor hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 100 (2003) 15504-15509
5. Giaccia A., Siim B.G., and Johnson R.S. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2 (2003) 803-811
6. Isaacs J.S., Jung Y.J., Mimnaugh E.G., Martinez A., Cuttitta F., and Neckers L.M. Hsp90 regulates a von Hippel-Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J. Biol. Chem. 277 (2002) 29936-29944
7. Jiang B.H., Rue E., Wang G.L., Roe R., and Semenza G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996) 17771-17778
8. Jones D.T., Pugh C.W., Wigfield S., Stevens M.F.G., and Harris A.L. Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-α expression but decrease functional transcriptional activity, DNA binding, and degradation. Clin. Cancer Res. 12 (2006) 5384-5394
9. Kaluz S., Kaluzova M., and Stanbridge E.J. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1α C-terminal activation domain. Mol. Cell Biol. 26 (2006) 5895-5907
10. Klausmeyer P., McCloud T.G., Melillo G., Scudiero D.A., Cardellina J.H., and Shoemaker R.H. Identification of a new natural camptothecin analogue in targeted screening for HIF-1α inhibitors. Planta. Med. 73 (2007) 49-52
11. Kong D., Park E.J., Stephen A.G., Calvani M., Cardellina J.H., Monks A., Fisher R.J., Shoemaker R.H., and Melillo G. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res. 65 (2005) 9047-9055
12. Kong X., Lin Z., Liang D., Fath D., Sang N., and Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol. Cell Biol. 26 (2006) 2019-2028
13. Kung A.L., Zabludoff S.D., France D.S., Freedman S.J., Tanner E.A., Vieira A., Cornell-Kennon S., Lee J., Wang B., Wang J., Memmert K., Naegeli H.U., et al. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6 (2004) 33-43
14. Mabjeesh N.J., Post D.E., Willard M.T., Kaur B., Van Meir E.G., Simons J.W., and Zhong H. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res. 62 (2002) 2478-2482
15. Mabjeesh N.J., Escuin D., LaVallee T.M., Pribluda V.S., Swartz G.M., Johnson M.S., Willard M.T., Zhong H., Simons J.W., and Giannakakou P. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3 (2003) 363-375
16. Melillo G. HIF-1: A target for cancer, ischemia and inflammation-too good to be true?. Cell Cycle 3 (2004) 154-155
17. Melillo G. Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol. Cancer Res. 4 (2006) 601-605
18. Nickols N.G., Jacobs C.S., Farkas M.E., and Dervan P.B. Improved nuclear localization of DNA-binding polyamides. Nucleic Acids Res. 35 (2007) 363-370
19. Olenyuk B.Z., Zhang G.J., Klco J.M., Nickols N.G., Kaelin Jr. W.G., and Dervan P.B. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc. Natl. Acad. Sci. USA 101 (2004) 16768-16773
20. Park E.J., Kong D., Fisher R., Cardellina J., Shoemaker R.H., and Melillo G. Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1. Cell Cycle 5 (2006) 1847-1853
21. Qian D.Z., Kachhap S.K., Collis S.J., Verheul H.M.W., Carducci M.A., Atadja P., and Pili R. Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α. Cancer Res. 66 (2006) 8814-8821
22. Rapisarda A., Uranchimeg B., Scudiero D.A., Selby M., Sausville E.A., Shoemaker R.H., and Melillo G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62 (2002) 4316-4324
23. Rapisarda A., Uranchimeg B., Sordet O., Pommier Y., Shoemaker R.H., and Melillo G. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: Mechanism and therapeutic implications. Cancer Res. 64 (2004) 1475-1482
24. Rapisarda A., Zalek J., Hollingshead M., Braunschweig T., Uranchimeg B., Bonomi C.A., Borgel S.D., Carter J.P., Hewitt S.M., Shoemaker R.H., and Melillo G. Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts. Cancer Res. 64 (2004) 6845-6848
25. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
26. Shoemaker R.H., Scudiero D.A., Melillo G., Currens M.J., Monks A.P., Rabow A.A., Covell D.G., and Sausville E.A. Application of high-throughput, molecular-targeted screening to anticancer drug discovery. Curr. Top. Med. Chem. 2 (2002) 229-246
27. Van Dyke M.M., and Dervan P.B. Echinomycin binding sites on DNA. Science 225 (1984) 1122-1127
28. Wang G.L., and Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood 82 (1993) 3610-3615
29. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. USA 90 (1993) 4304-4308
30. 2 tension. Proc. Natl. Acad. Sci. USA 92 (1995) 5510-5514
31. Welsh S., Williams R., Kirkpatrick L., Paine-Murrieta G., and Powis G. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol. Cancer Ther. 3 (2004) 233-244
32. Welsh S.J., Williams R.R., Birmingham A., Newman D.J., Kirkpatrick D.L., and Powis G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. Mol. Cancer Ther. 2 (2003) 235-243
33. Yang J., Zhang L., Erbel P.J., Gardner K.H., Ding K., Garcia J.A., and Bruick R.K. Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor. J. Biol. Chem. 280 (2005) 36047-36054
34. Yeo E.J., Chun Y.S., Cho Y.S., Kim J., Lee J.C., Kim M.S., and Park J.W. YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl. Cancer Inst. 95 (2003) 516-525